Home-Based Exercise Program Using Mobile Technology After Left Ventricular Assist Device Implantation

Status: Recruiting
Location: See all (4) locations...
Intervention Type: Behavioral
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

The goal of this clinical trial is to evaluate the effects of a home-based exercise program using mobile technology on physical activity and capacity, frailty and muscle mass, and quality of life in patients with a newly implanted HeartMate 3 left ventricular assist device (HM3 LVAD). Researchers will compare the effects of an exercise intervention vs. usual care on physical activity and capacity, frailty and muscle mass, and quality of life.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:

• ≥ 18 years of age

• Newly implanted with a HeartMate 3™ LVAD for the first time

• Able to ambulate independently (with or without the use of an assistive device)

• Owns a smartphone with Internet connection

• Patient will be discharged home with LVAD or patient will be living at home with LVAD within 45 days of index discharge

Locations
United States
Michigan
Henry Ford Health
RECRUITING
Detroit
Ohio
Cleveland Clinic Foundation
RECRUITING
Cleveland
Pennsylvania
University of Pennsylvania
RECRUITING
Philadelphia
Utah
University of Utah Health
RECRUITING
Salt Lake City
Contact Information
Primary
Clinical Research Coordinator
sadie.butcher@pennmedicine.upenn.edu
215-615-4480
Time Frame
Start Date: 2024-08-14
Estimated Completion Date: 2028-06-30
Participants
Target number of participants: 100
Treatments
Experimental: Exercise Intervention
The exercise intervention focuses on walking and strengthening exercises with a standardized protocol to guide exercise prescription and exercise progression based on data obtained from the activity tracking watch and smartphone app.
Other: Usual Care
The usual care group will be encouraged to increase daily walking activity as they tolerate, while complying with any activity restrictions from their clinical team. The Physical Activity Guidelines for Americans recommend increasing daily walking activity as tolerated to an average of 30 minutes daily, 5 times a week.
Related Therapeutic Areas
Heart Failure
Sponsors
Leads: University of Pennsylvania
Collaborators: National Heart, Lung, and Blood Institute (NHLBI)

This content was sourced from clinicaltrials.gov

Similar Clinical Trials

The Effect of Exercise Training Intervention and Detraining on Frailty and Fall Risk in Patients With Chronic Heart Failure.

The Effect of Exercise Training Intervention and Detraining on Frailty and Fall Risk in Patients With Chronic Heart Failure.

Enrollment Status: Recruiting
Publish Date: August 11, 2025
Intervention Type: Other
Study Phase: Not Applicable

Pilot Study to Evaluate the Efficacy of Low Dose Colchicine (LoDoCo ®) to Improve Exercise Capacity Among Patients With Chronic Stable HFpEF and Systemic Inflammation

Pilot Study to Evaluate the Efficacy of Low Dose Colchicine (LoDoCo ®) to Improve Exercise Capacity Among Patients With Chronic Stable HFpEF and Systemic Inflammation

Enrollment Status: Recruiting
Publish Date: April 25, 2025
Intervention Type: Drug
Study Phase: Phase 2

Heart-eXg Study: Effects of Exergaming to Reduce Sedentary Time in Inactive Patients With Heart Failure: An International Multi-center, Randomized, Parallel-group Study

Heart-eXg Study: Effects of Exergaming to Reduce Sedentary Time in Inactive Patients With Heart Failure: An International Multi-center, Randomized, Parallel-group Study

Enrollment Status: Recruiting
Publish Date: December 11, 2024
Intervention Type: Other
Study Phase: Not Applicable
View All